Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
Hausen, A; Fuchs, D; Reibnegger, G; Wachter, H.
Urinary pteridines on patients suffering from cancer. A comment on the method and results of Rao and associates and of Trehan and associates.
CANCER. 1984; 53(7): 1634-1636.
Doi: 10.1002/1097-0142(19840401)53:7<1634::AID-CNCR2820530736>3.0.CO;2-8
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Co-Autor*innen der Med Uni Graz
- Reibnegger Gilbert
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- A diagnostic test for detecting malignancies has been reported by Rao and associates. This test has been extended by Trehan and associates as an index of disease status in acute myeloblastic leukemic patients on antileukemic drugs. The authors were able to demonstrate that by using the described assay various pteridines are measured and not exclusively 6-hydroxymethylpterin as reported by the above-mentioned authors. Furthermore, the urinary component which correlates to the status of malignant disease has to be interpreted as being neopterin. This conclusion can be drawn from previous studies conducted by the authors' laboratory.
- Find related publications in this database (using NLM MeSH Indexing)
- Biopterin - analogs and derivatives
- Charcoal - analogs and derivatives
- Chromatography, High Pressure Liquid - analogs and derivatives
- Humans - analogs and derivatives
- Leukemia, Myelocytic, Acute - urine
- Neopterin - urine
- Pteridines - isolation and purification
- Pterins - urine
- Spectrometry, Fluorescence - urine